Camp4 Therapeutics FY25 GAAP EPS missed expectations, but ended the year with a robust cash position. Check out why CAMP ...

Results show that targeting the underlying cause of Dravet syndrome with zorevunersen may improve outcomes for people with ...

TD Cowen 46th Annual Health Care Conference March 4, 2026 9:50 AM ESTCompany ParticipantsAlexander Schuth - Co-Founder, ...

Spinraza treatment led to sustained improvements in motor function in adults with SMA, according to a South Korean study.

An ongoing Phase III trial aims to further evaluate the drug's clinical efficacy in reducing seizures and affecting behavior and cognition.

The Social Security Administration quietly corrected a blog post that had asserted that the recent federal budget bill eliminated taxes on Social Security and offered a bigger tax deduction for ...

In recent days, Stoke Therapeutics and Biogen reported that data on the investigational Dravet syndrome medicine zorevunersen were published in The New England Journal of Medicine, alongside Stoke’s ...

Lots of people are talking about peptides. But what are they? Here’s a quick primer on the health trend and what we know about peptides’ safety.

U.S. service members, Kenya Defence Forces and local civilian medical teams delivered critical healthcare to Samburu County ...

Many Latino immigrants avoid public benefits because of fears about their immigration status or that of family members, which is heightened by anti-immigration rhetoric. This study used data from the ...

Experts weigh in on whether these stickers live up to the hype.

FDA IND clearance enables a phase 3 program evaluating TRIESENCE for postoperative ocular inflammation and pain following cataract surgery, aiming to broaden on-label use beyond current intraocular ...